Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Falling Comet
1699.8000 33.40 (2.00%)
NSE May 29, 2025 15:31 PM
Volume: 2.4M
 

logo
Sun Pharmaceutical Industries Ltd.
01 Feb 2025
1699.80
2.00%
buy
by BOB Capital Markets Ltd.
Target: 2086 | Upside : 22.7%
BOB Capital Markets Ltd.
Domestic sales grew by 14% in Q3FY25 driven partially by volume/new launches and price hikes. Strong domestic sales growth to continue
 
Sun Pharmaceutical I.. has an average target of 2039.89 from 9 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes higher, Alkem Labs' Q4 net profit rises 4.2% YoY to Rs 305.9 crore
Trendlyne Marketwatch | 29 May 2025, 04:09PM
Nifty 50’s annual winners: Top-performing stocks of the past decade
The Baseline | 29 May 2025, 01:00PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022